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ABSTRACT
A case of severe and irreversible pancytopenia secondary to acute primary cytomegalovirus infec-
tion in an immunocompetent woman is described. The patient presented with thrombocytopenia, 
lymphopenia, anemia, and abnormal liver function tests. Treatment with corticosteroids and intra-
venous immunoglobulin was ineffective in reconstituting hemopoiesis. The patient developed severe 
sepsis and eventually expired.
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INTRODUCTION AND OBJECTIVE
Human cytomegalovirus (CMV) is a β human 
herpesvirus and a member of Herpesviridae 
family and can cause life-threatening infections 
in immunocompromised patients. CMV infec-
tion in healthy host, on the contrary, is either 
asympomatic and resolves spontaneously or, in 
rare occasions, can cause a self-limited mono-
nucleosis-like syndrome presented with fever, 
myalgia, hepatitis, and cervical adenopathy.1 
Signifi cant involvement of hematopoietic sys-
tem due to acute CMV infection in immunocom-
petent patients is scarcely reported in literature.2-6
We describe a case of fulminant pancytope-
nia secondary to CMV infection in a previously 
healthy woman. To our knowledge, no other 
case of sustained and irreversible leukopenia 
and thrombocytopenia with subsequent death 
due to bacterial sepsis in an immunocompetent 
individual has been reported so far, except for a 
case of disseminated CMV infection in an ap-
parently normal adult.2
CLINICAL PRESENTATION
A 61-year-old woman was admitted to our hos-
pital due to persistent diarrhea, malaise, loss of 
appetite, and weight loss one month prior to 
admission. She denied any health problems and 
use of medications. Her past medical history 
revealed cholecystectomy and appendicectomy 
more than 10 years ago. On physical examination, 
jaundice and hepatosplenomegaly were present. 
Laboratory examination showed mild anemia 
[hematocrit (Ht): 35.6%], leukopenia with lym-
phopenia [white blood cells (WBC): 3,030/µL, 
lymphocytes: 600/µL] and thrombocytopenia 
[platelet count (PLT): 129,000/µL] (Figure 1A). 
Biochemistry revealed elevated liver function 
tests [serum glutamic oxaloacetic transaminase 
(SGOT): 1,066 IU/L, serum glutamate pyruvate 
transaminase (SGPT): 598 IU/L, alkaline phos-
phatase (ALP): 627 IU/L, γ-glutamyl transpepti-
dase (γ-GT): 568 IU/L, total bilirubin: 13.21 
mg/dL, direct bilirubin: 10.41 mg/dL, indirect 
bilirubin: 2.8 mg/dL) (Figure 1B). Abdominal 
ultrasound and computed tomography revealed 
mild hepatosplenomegaly. Serum antibodies for 
hepatitis B and C, human immunodefi ciency vi-
rus, Epstein-Barr virus, herpes simplex viruses 1 
and 2, herpes zoster virus, parvovirus, coxsackie 
and ECHO virus were negative, except for posi-
tive IgM and IgG antibodies against CMV de-
tected with indirect immunoﬂ uorescence (IFA 
CMV test; Gull Laboratories, Salt Lake City, UT, 
USA). Serology tests for Rickettsia conorii or R. 
mooseri, Coxiella burnetti, Leptospira sp., Leish-
mania sp. and Brucella sp. were also negative. 
The patient was stable 10 days following ad-
mission with resolution of diarrhea and gradual 
recovery of liver function tests (Figure 1B). PLT 
count further decreased (Figure 1A). Peripher-
al blood smear showed abnormal distribution 
of PLT and thrombocytopenia, anisocytosis 
of red blood cells together with lymphopenia. 
Bone marrow aspiration indicated reactive cel-
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lularity. More specifi cally, erythroid cell line matured with 
megaloblastic characteristics, myeloid cell line showed white 
blood cell left shift, and megacaryotic cell line had normal 
representation. A slight increase of macrophages was also 
noted with no signs of hemophagocytosis. Moreover, re-
ticulocytes represented 2.13% in peripheral blood. Auto-
antibodies (anti-nuclear, anti-endothelial cell, anti-smooth-
muscle cell antibodies), anti-platelet antibodies, Coombs’ 
and cryoglobulin tests were negative. Complement, plasma 
hemoglobin, and haptoglobin levels were within normal 
limits. Both viral load of CMV measured with real-time 
PCR and CMV pp65 antigen in peripheral WBC and bone 
marrow samples were undetectable. Titers of IgM and IgG 
antibodies were 1/80 and 1/640, respectively, suggesting pri-
mary CMV infection or reactivation. Immunophenotyping 
of peripheral white blood cells showed a marked decrease of 
CD4 T-lymphocytes (7%), B-lymphocytes (1%), and natu-
ral killer cells (2%), along with major increase of CD8 T-
lymphocytes (84.9%) supportive of CMV infection. 
Upon diagnosis of acute CMV infection, treatment with 
prednisolone (50 mg/day for 10 days), intravenous im-
munoglobulin (IVIg) (0.4mg/kg for 5 days) and ganciclo-
vir (5 mg/kg twice daily IV) was initiated. Despite therapy, 
thrombocytopenia and neutropenia worsened, requiring 
granulocyte-colony stimulating factor (G-CSF) and PLT 
transfusions. On day 30, patient developed febrile neutrope-
nia. Blood cultures yielded Serratia marcescens and, despite 
appropriate antibiotics and supportive measurements, she 
expired on day 43. Neutropenia and thrombocytopenia were 
never resolved. 
 
DISCUSSION 
A previously healthy woman presented with generalized ma-
laise, jaundice, elevated liver function biochemical markers 
and mild anemia, leukopenia and thrombocytopenia. Di-
agnosis of primary CMV infection was based on identifi -
cation of positive IgM antibodies in a high titer, which are 
considered highly specifi c and sensitive in immunocompe-
tent hosts.7 CMV infection induced sustained and irrevers-
ible pancytopenia, despite normal fi ndings in bone marrow 
aspiration. 
In immunocompetent hosts, primary CMV infection 
is usually asymptomatic or it could present as a mononu-
cleosis syndrome. Diagnosis is based on clinical presen-
tation and seroconversion. Detection and quantification 
of viral load can be used to monitor and predict CMV 
disease, especially in immunocompromised patients. In 
a study of dynamics of primary CMV infection in 48 im-
munocompetent patients, it was reported that 43% of 
examined serum samples (37/87) from 27 of these 48 pa-
tients (56.8%) had detectable CMV DNA.8 Even though 
viral load has been correlated with development of CMV 
disease in transplant recipients, invasive CMV gastroin-
testinal or retinal disease may have undetectable viral 
load.9,10 Therefore, based on published studies of CMV 
kinetics, diagnosis of primary CMV infection is relied 
on seroconversion without compulsory detection of viral 
DNA, as it was noticed in the case described.
Several mechanisms have been proposed on the effect 
of CMV on hematopoiesis in immunocompetent hosts. 
One mechanism indicates direct effect of CMV on bone 
marrow cells leading to cellular injury and decrease of 
erythrocytes, lymphocytes, granulocytes, and platelets. 
Several in vitro studies have shown the ability of certain 
strains of CMV to infect hematopoietic progenitor cells 
and subsequently inhibit hemopoiesis.11 In addition, it 
has been suggested that CMV infection results in down-
regulation of G-CSF and hematopoietic suppression.12 
In our case, bone marrow aspiration showed normal cel-
lularity and CMV antigen was not detected. Therefore, 
this mechanism should not be the cause of pancytopenia. 
However, reticulocyte count in peripheral blood, an indi-
Figure 1: Time course of leukocytes and platelets (A) and 
liver function tests (B) during patient hospitalization.WBC, 
white blood cell; PLT, platelets; SGOT, serum glutamic 
oxaloacetic transaminase; SGPT, serum glutamate pyruvate 
transaminase; ALP, alkaline phosphatase; γ-GT, γ-glutamyl 
transpeptidase.
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rect marker of bone marrow erythroid cell line function, 
showed a marked decrease from day 20 to day 42.
In addition, hemophagocytosis triggered by CMV 
could result in proliferation of mature histiocytes that de-
stroy hematopoietic cells. Although hemophagocytic syn-
drome typically occurs in patients with malignant diseas-
es, acquired immunodeficiency syndrome, bone marrow 
or solid organ transplantation and in those with autoim-
mune diseases receiving immunomodulating therapies, 
very few cases have been reported in immunocompetent 
patients. Two cases of gastrointestinal complications with 
hemophagocytic syndrome caused by CMV infection 
have been described.13 Nevertheless, no evidence of he-
mophagocytosis was found in our case.
Immunological mechanisms involve the formation of 
anti-platelets, anti-endothelial cells, anti-smooth-muscle 
cells, anti-nuclear antibodies, and cryoglobulins that link 
CMV infection with thrombocytopenia, autoimmune 
disorders, and haemolysis. Molecular mimicry has been 
implicated in onset of autoimmunity. Viral peptides that 
share homology with host-peptides could initiate an im-
mune response both against itself and the virus. Addi-
tionally, during viral cell lysis, intracellular proteins, the 
secured host antigens not previously recognized, are ex-
posed to circulating antigen-presenting cells that activate 
autoreactive lymphocytes.14 Consequently, bone marrow 
necrosis should be accompanied by formation of autoan-
tibodies. Soderberg et al. reported a correlation between 
CMV induced formation of antibodies against CD13, 
which is expressed on myelomonocytic cells, and the de-
velopment of graft-versus-host disease following alloge-
neic bone marrow transplantation.15
Cell destruction in the periphery should be attributed 
to an immunological mechanism. Previously published 
case reports confirm that anti-platelet antibodies are rare-
ly detected during the acute phase of CMV infection.4,6 
Thus, it is most likely that in our patient autoimmunity 
was responsible for CMV-induced pancytopenia, despite 
the absence of anti-platelet antibodies.
Despite intensive supportive treatment, recovery of 
hematopoiesis was not achieved. Initial corticosteroid ad-
ministration and IVIg were given for presumed immuno-
logical origin of thrombocytopenia and lymphopenia. 
CONCLUSION 
In conclusion, even though CMV infection in immuno-
competent adults is usually asymptomatic, only in rare cases 
CMV could affect hematopoiesis because of autoimmune 
mechanisms, manifested either as thrombocytopenia or 
hemolytic anemia. This case presents a previously healthy 
woman who developed irreversible pancytopenia secondary 
to CMV infection. Therapeutic interventions were ineffec-
tive, leading to patient’s death. Therefore, CMV infection 
should be considered in immunocompetent individuals 
with unexplained and refractory cytopenias. 
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